| Todd J Lundquist, PHARMD | |
|
1450 N 2nd E, Rexburg, ID 83440-5131 | |
| (208) 359-2814 | |
| (208) 359-2816 |
| Full Name | Todd J Lundquist |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 1450 N 2nd E, Rexburg, Idaho |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093224842 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | P7820 (Idaho) | Secondary |
| 183500000X | Pharmacist | 4003 (Wyoming) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Todd J Lundquist, PHARMD 1450 N 2nd E, Rexburg, ID 83440-5131 Ph: (208) 359-2814 | Todd J Lundquist, PHARMD 1450 N 2nd E, Rexburg, ID 83440-5131 Ph: (208) 359-2814 |
News Archive
MedAssets today announced that Advocate Health Care, a 12-hospital, 3,300-bed health system based in Downers Grove, Ill., renewed its performance improvement relationship with MedAssets to drive sustainable cost reductions, improve operational efficiencies and ultimately, the standard of care. The renewal builds upon Advocate's recent success in total cost management initiatives including MedAssets Strategic Sourcing, Capital and Construction, Procure-to-Pay solutions and Cost Analytics.
Idenix Pharmaceuticals, Inc., a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced the advancement of its hepatitis C virus development pipeline.
Ardea Biosciences, Inc. announced positive results from the first dosing group of an ongoing drug-drug interaction and pharmacodynamic study of RDEA594, its lead product candidate for the treatment of hyperuricemia and gout, and febuxostat (Uloric®, Takeda Pharmaceutical Company Limited; Adenuric®, Ipsen). This
Making it easier to obtain emergency contraception would not increase unprotected intercourse, lead to abandonment of regular contraception, or increase the risk of sexually transmitted infections (STIs), according to a study in the January 5 issue of JAMA.
Debiopharm Group (Debiopharm) and Spinomix SA, a Swiss company advancing molecular diagnostic technologies, announced the closing of a Series A equity investment of $ 3 Million.
› Verified 8 days ago
Mallory Chapman, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1450 N 2nd E, Rexburg, ID 83440 Phone: 208-359-2814 | |
Dustin Boyd Stacey, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 72 S 1st E, Rexburg, ID 83440 Phone: 208-372-8300 | |
Dr. Erik Bergstrom, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 164 E Main St, Rexburg, ID 83440 Phone: 208-227-5076 Fax: 208-227-5079 | |
Dr. Scott J Webster, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 530 N 2nd E, Rexburg, ID 83440 Phone: 208-359-2814 Fax: 208-359-1937 | |
Dee W Atkinson, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 490 N 2nd E, Rexburg, ID 83440 Phone: 208-542-2088 Fax: 208-542-2089 | |
Zachary Rex Gundersen, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 164 E Main St, Rexburg, ID 83440 Phone: 208-227-5076 |